{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:04:38Z","timestamp":1789682678888,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijrobp.2024.11.067","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T17:20:06Z","timestamp":1731864006000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-1490","authenticated-orcid":false,"given":"Michael","family":"Dohopolski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Giuliani","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soummitra","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Strahinja","family":"Stojadinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toral","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinJae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-8415","authenticated-orcid":false,"given":"Zabi","family":"Wardak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.11.067_bib0001","series-title":"Brain Metastasis","author":"Amsbaugh","year":"2024"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0002","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology for CNS V.1.2023. 2023. Accessed February 13, 2024. http:\/\/www.nccn.org"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0003","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0004","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1200\/JCO.22.00333","article-title":"Radiation therapy for brain metastases: ASCO guideline endorsement of ASTRO guideline","volume":"40","author":"Schiff","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0005","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0006","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3 \u00d7 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0007","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers13010070","article-title":"The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases","volume":"13","author":"Gutschenritter","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0009","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single and multi-fraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano","year":"2021","journal-title":"Int J Radiat Oncol Biol Phy"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3171\/2017.3.JNS162532","article-title":"Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases >= 2 cm","volume":"129","author":"Angelov","year":"2018","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0011","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ijrobp.2008.10.035","article-title":"Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors","volume":"74","author":"Higuchi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1748-717X-9-132","article-title":"A minimally invasive treatment option for large metastatic brain tumors: Long-term results of two- session gamma knife stereotactic radiosurgery","volume":"9","author":"Yomo","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11060-012-0882-8","article-title":"A prospective pilot study of two-session gamma knife surgery for large metastatic brain tumors","volume":"109","author":"Yomo","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2023.07.143","article-title":"Comparison of staged stereotactic radiosurgery and fractionated stereotactic radiotherapy in patients with brain metastases >2cm without prior whole brain radiotherapy: A systematic review and meta-analysis","volume":"178","author":"Harikar","year":"2023","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109920","article-title":"Factors associated with radiation necrosis and intracranial control in patients treated with immune checkpoint inhibitors and stereotactic radiotherapy","volume":"189","author":"Hall","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0016","doi-asserted-by":"crossref","unstructured":"Martin AM, Cagney DN, Catalano PJ, et al. Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation. JAMA Oncol. 2048;4:1123-1124. doi:10.1001\/jamaoncol.2017.3993","DOI":"10.1001\/jamaoncol.2017.3993"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0017","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized ultrafractionated stereotactic adaptive radiotherapy (pulsar) in preclinical models enhances single-agent immune checkpoint blockade","volume":"110","author":"Moore","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0018","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/mp.14722","article-title":"A general algorithm for distributed treatments of multiple brain metastases","volume":"48","author":"Chen","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2018.02.029","article-title":"Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (patriot): A phase 2 randomized trial","volume":"127","author":"Quon","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.radonc.2013.06.045","article-title":"Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: A comparison of acute toxicity and quality of life","volume":"108","author":"Jain","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0021","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11060-016-2317-4","article-title":"Multisession gamma knife surgery for large brain metastases","volume":"131","author":"Hasegawa","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0022","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-020-03421-y","article-title":"Comparison of two-stage gamma knife radiosurgery outcomes for large brain metastases among primary cancers","volume":"147","author":"Ito","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0023","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3171\/2018.4.JNS172596","article-title":"Comparison of treatment results between 3- and 2-stage gamma knife radiosurgery for large brain metastases: a retrospective multi-institutional study","volume":"131","author":"Serizawa","year":"2019","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0024","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/j.wneu.2022.01.109","article-title":"Metastatic neoplasm volume kinetics following 2-stage stereotactic radiosurgery","volume":"161","author":"Damron","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0025","first-page":"105","article-title":"Two-staged stereotactic radiosurgery for the treatment of large brain metastases: Single institution experience and review of literature","volume":"7","author":"Ginalis","year":"2020","journal-title":"J Radiosurg S.B.R.T"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0026","first-page":"1","article-title":"Emerging systemic treatment perspectives on brain metastases: Moving toward a better outlook for patients","volume":"42","author":"Alvarez-Breckenridge","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0027","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/1078-0432.CCR-16-0399","article-title":"Preclinical comparison of osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity","volume":"22","author":"Ballard","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0028","first-page":"156","article-title":"Systemic treatment options for brain metastases from non-small-cell lung cancer","volume":"32","author":"Bulbul","year":"2018","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0029","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ijrobp.2017.11.041","article-title":"Concurrent immune checkpoint inhibitors and stereotactic radiosurgery for brain metastases in non-small cell lung cancer, melanoma, and renal cell carcinoma","volume":"100","author":"Chen","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtho.2019.11.004","article-title":"Brigatinib in crizotinib-refractory ALK+ NSCLC: 2-year follow-up on systemic and intracranial outcomes in the phase 2 ALTA trial","volume":"15","author":"Huber","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0031","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO\u2013ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41523-023-00587-2","article-title":"Pertuzumab plus high-dose trastuzumab for her2-positive breast cancer with brain metastases: PATRICIA final efficacy data","volume":"9","author":"Lin","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0033","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jtho.2021.06.020","article-title":"Outcomes with pembrolizumab plus platinum-based chemotherapy for patients with NSCLC and stable brain metastases: Pooled analysis of keynote-021, -189, and -407","volume":"16","author":"Powell","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0034","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0035","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.3390\/cancers13153682","article-title":"Integration of systemic therapy and stereotactic radiosurgery for brain metastases","volume":"13","author":"Tonse","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0036","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ijrobp.2023.12.002","article-title":"Long-term intracranial outcomes with combination dual immune-checkpoint blockade and stereotactic radiosurgery in patients with melanoma and non-small cell lung cancer brain metastases","volume":"118","author":"Vaios","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0037","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/neuros\/nyx355","article-title":"Staged stereotactic radiosurgery for large brain metastases: Local control and clinical outcomes of a one-two punch technique","volume":"83","author":"Dohm","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ijrobp.2024.11.067_bib0038","article-title":"Volumetric regression in brain metastases after stereotactic radiotherapy: Time course, predictors, and significance","volume":"10","author":"Oft","year":"2020","journal-title":"Front Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624036411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624036411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:22:44Z","timestamp":1749201764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624036411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0360301624036411"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.067","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases Treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.11.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}